← Leaderboards
Mahesh P Gupta
University Of Chicago
$12,529,486
Attributed
$12,529,486
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $965.7K · FY2005–21$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$12,529,486 · 7
By mechanism
R01$12,529,486 · 7
Top collaborators
No co-investigators on record.
Most similar at University Of Chicago
Same institution · by research overlap
- Anne I. Sperling$25,843,318
Others in their field
Top investigators on “Heart Failure”
- Judith S Hochman · New York University School Of Medicine$120,321,606
- David T Mauger · Pennsylvania State Univ Hershey Med Ctr$51,947,333
- Lisa P Jacobson · Johns Hopkins University$45,397,923
- Walter N Kernan · Yale University$42,197,025
- Dalane W Kitzman · Wake Forest University$40,701,149
- David Couper · Univ Of North Carolina Chapel Hill$37,959,091
Research focus
Heart FailureBaseHeartCell GrowthCardiacSirtuinsLongevityLaboratoriesFibrosisOxidative StressTransgenic MiceSignal TransductionHeart HypertrophyResponseMediatingCell NucleusCellsMitochondriaProtein IsoformsCardiac MyocytesNovel TherapeuticsEnzymesBiological ProcessMyocardium
Grant awards (29)
Exploring roles of sirtuins in protecting diabetic hearts$468,268
R01 · FY2021 · HL · contact PI
Improving post-surgery recovery of failing hearts by targeting cardiomyocyte senescence$430,115
R01 · FY2021 · HL · contact PI
Exploring roles of sirtuins in protecting diabetic hearts$468,268
R01 · FY2020 · HL · contact PI
Improving post-surgery recovery of failing hearts by targeting cardiomyocyte senescence$430,115
R01 · FY2020 · HL · contact PI
Exploring roles of sirtuins in protecting diabetic hearts$469,431
R01 · FY2019 · HL · contact PI
Improving post-surgery recovery of failing hearts by targeting cardiomyocyte senescence$430,115
R01 · FY2019 · HL · contact PI
Exploring roles of sirtuins in protecting diabetic hearts$482,604
R01 · FY2018 · HL · contact PI
Improving post-surgery recovery of failing hearts by targeting cardiomyocyte senescence$430,115
R01 · FY2018 · HL · contact PI
Blocking cardiac toxicity of anticancer drugs$448,023
R01 · FY2016 · HL · contact PI
Activation of sirtuins to prevent adverse cardiac remodeling after CABG$395,000
R01 · FY2016 · HL · contact PI
Blocking cardiac toxicity of anticancer drugs$441,129
R01 · FY2015 · HL · contact PI
Activation of sirtuins to prevent adverse cardiac remodeling after CABG$389,075
R01 · FY2015 · HL · contact PI
Blocking cardiac toxicity of anticancer drugs$439,139
R01 · FY2014 · HL · contact PI
Activation of sirtuins to prevent adverse cardiac remodeling after CABG$387,100
R01 · FY2014 · HL · contact PI
Blocking cardiac toxicity of anticancer drugs$426,031
R01 · FY2013 · HL · contact PI
Activation of sirtuins to prevent adverse cardiac remodeling after CABG$395,000
R01 · FY2013 · HL · contact PI
The Role of PARP-SIR2 Signaling in Heart Failure$486,915
R01 · FY2011 · HL · contact PI
The Role of PARP-SIR2 Signaling in Heart Failure$491,959
R01 · FY2010 · HL · contact PI
The Role of PARP-SIR2 Signaling in Heart Failure$502,804
R01 · FY2009 · HL · contact PI
The Role of PARP-SIR2 Signaling in Heart Failure$528,123
R01 · FY2008 · HL · contact PI
Histone deacetylases in pathogenesis of heart failure$537,722
R01 · FY2007 · HL · contact PI
The Role of PARP-SIR2 Signaling in Heart Failure$427,954
R01 · FY2007 · HL · contact PI
Histone deacetylases in pathogenesis of heart failure$548,207
R01 · FY2006 · HL · contact PI
Histone deacetylases in pathogenesis of heart failure$452,715
R01 · FY2005 · HL
Histone deacetylases in pathogenesis of heart failure$439,529
R01 · FY2004 · HL
Alpha-Myosin Heavy Chain Gene Repression &Heart Failure$278,030
R01 · FY2004 · HL
Alpha-Myosin Heavy Chain Gene Repression &Heart Failure$302,000
R01 · FY2003 · HL
Alpha-Myosin Heavy Chain Gene Repression &Heart Failure$302,000
R01 · FY2002 · HL
Alpha-Myosin Heavy Chain Gene Repression &Heart Failure$302,000
R01 · FY2001 · HL